PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
Public ClinicalTrials.gov record NCT06422871. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PReSeRVE-HD: PRospective, Multicenter, Observational Study of the Merit HeRO® Graft and Super HeRO® EValuated in End-Stage Renal Disease Patients on HemoDialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this observational study is to increase the understanding of the safety and performance of Merit Medical's HeRO Graft System (HeRO) and Super HeRO Adaptor and Support Seal System (Super HeRO) devices. This study includes adults that are being treated with one of these devices as part of their regular medical care for maintaining long-term dialysis access when all other dialysis access options have failed. If participants in the study are not seen for a standard of care clinic visit during the 4 visit timepoints over 2 years, the participant will be followed by phone to check their current health and dialysis status.
Study identification
- NCT ID
- NCT06422871
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 100 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2025
- Primary completion
- Jun 27, 2027
- Completion
- Dec 27, 2028
- Last update posted
- May 31, 2026
2025 – 2028
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Sarasota Memorial Health Care System | Sarasota | Florida | 34239 | Recruiting |
| WakeMed | Raleigh | North Carolina | 27610 | Recruiting |
| University Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15219 | Recruiting |
| Baylor Scott & White Heart and Vascular Hospital - Dallas | Dallas | Texas | 75226 | Recruiting |
| Houston Methodist Hospital | Houston | Texas | 77030 | Recruiting |
| Sentara Norfolk General Hospital | Norfolk | Virginia | 23507 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated End Stage Renal Disease trials
Other public records listing End Stage Renal Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT04163614: Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients Recruiting
- NCT06516653: Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula Recruiting
- NCT07696962: Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease Not yet recruiting
- NCT04392206: AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses Recruiting
- NCT03674307: Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates Active, not recruiting
- NCT06182475: Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3 Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06422871, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2026 · Synced Jul 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06422871 live on ClinicalTrials.gov.